Hikari Power LTD Has Upped Synergy Pharmaceuticals (SGYP) Stake; Windacre Partnership Has Lifted Transdigm Group (TDG) Holding

May 21, 2018 - By Ellis Scott

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Logo

Hikari Power Ltd increased Synergy Pharmaceuticals Inc (SGYP) stake by 26.67% reported in 2017Q4 SEC filing. Hikari Power Ltd acquired 400,000 shares as Synergy Pharmaceuticals Inc (SGYP)’s stock declined 21.49%. The Hikari Power Ltd holds 1.90M shares with $4.24 million value, up from 1.50 million last quarter. Synergy Pharmaceuticals Inc now has $404.65M valuation. The stock decreased 1.20% or $0.02 during the last trading session, reaching $1.64. About 1.97M shares traded. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has declined 62.55% since May 21, 2017 and is downtrending. It has underperformed by 74.10% the S&P500.

Windacre Partnership Llc increased Transdigm Group Inc (TDG) stake by 14.5% reported in 2017Q4 SEC filing. Windacre Partnership Llc acquired 112,100 shares as Transdigm Group Inc (TDG)’s stock rose 12.74%. The Windacre Partnership Llc holds 885,200 shares with $243.09M value, up from 773,100 last quarter. Transdigm Group Inc now has $17.31B valuation. The stock increased 1.78% or $5.77 during the last trading session, reaching $330.1. About 249,807 shares traded. TransDigm Group Incorporated (NYSE:TDG) has risen 54.52% since May 21, 2017 and is uptrending. It has outperformed by 42.97% the S&P500.

More notable recent Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) news were published by: Seekingalpha.com which released: “Synergy Pharmaceuticals Investors: Refocus Away From Management” on May 17, 2018, also Seekingalpha.com with their article: “Synergy Pharmaceuticals: The Short Covering Has Begun” published on May 13, 2018, Seekingalpha.com published: “Synergy Pharmaceuticals: Q1 Earnings Preview” on April 30, 2018. More interesting news about Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) were released by: Seekingalpha.com and their article: “Synergy Pharmaceuticals’ (SGYP) CEO Troy Hamilton on Q1 2018 Results – Earnings Call Transcript” published on May 10, 2018 as well as Seekingalpha.com‘s news article titled: “Synergy Pharmaceuticals: Best Drug + Terrible Management = Terrible Investment” with publication date: April 23, 2018.

Investors sentiment decreased to 1.22 in Q4 2017. Its down 0.68, from 1.9 in 2017Q3. It is negative, as 21 investors sold SGYP shares while 34 reduced holdings. 24 funds opened positions while 43 raised stakes. 125.65 million shares or 14.56% less from 147.06 million shares in 2017Q3 were reported. Palisade Management Llc Nj reported 73,774 shares. Barclays Plc owns 54,444 shares. Ingalls & Snyder Ltd accumulated 10,000 shares. State Street has 20.45 million shares. 104,372 are owned by Voya Management. Bancorp Of Ny Mellon has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 1.08M shares. Schwab Charles Inv Management invested 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Signaturefd Limited Company reported 10,000 shares. 169,802 were reported by Proshare Advisors Limited Liability. Cornerstone Ltd Liability Corp has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Balyasny Asset Mngmt holds 0.01% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 1.68M shares. Metropolitan Life Ins Com reported 83,788 shares. Geode Cap Ltd Liability Com owns 1.99 million shares or 0% of their US portfolio. Pub Employees Retirement Association Of Colorado holds 0% or 13,866 shares in its portfolio. Moreover, Prudential has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP).

Among 8 analysts covering Synergy Pharmaceuticals (NASDAQ:SGYP), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Synergy Pharmaceuticals has $20 highest and $2.5 lowest target. $9.17’s average target is 459.15% above currents $1.64 stock price. Synergy Pharmaceuticals had 46 analyst reports since August 25, 2015 according to SRatingsIntel. On Wednesday, October 18 the stock rating was maintained by H.C. Wainwright with “Buy”. H.C. Wainwright initiated Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) rating on Thursday, October 1. H.C. Wainwright has “Buy” rating and $20 target. Rodman & Renshaw maintained the shares of SGYP in report on Friday, January 20 with “Buy” rating. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, January 25. Cantor Fitzgerald maintained Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) rating on Wednesday, August 9. Cantor Fitzgerald has “Buy” rating and $1100 target. The stock has “Buy” rating by BTIG Research on Tuesday, August 1. Canaccord Genuity maintained Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) on Thursday, January 25 with “Buy” rating. The rating was maintained by Cantor Fitzgerald on Tuesday, November 21 with “Buy”. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has “Buy” rating given on Wednesday, October 11 by H.C. Wainwright. The company was maintained on Friday, January 26 by BTIG Research.

More notable recent TransDigm Group Incorporated (NYSE:TDG) news were published by: Seekingalpha.com which released: “TransDigm Group (TDG) Q2 2018 Results – Earnings Call Transcript” on May 01, 2018, also Streetinsider.com with their article: “Lone Pine’s 13F Shows New Stake in Dollar Tree (DLTR), Square (SQ), T-Mobile (TMUS) (more…)” published on May 15, 2018, Globenewswire.com published: “Recent Analysis Shows DTE Energy, Transdigm Group, Ringcentral, Resonant, Hudson Technologies, and Houghton …” on May 14, 2018. More interesting news about TransDigm Group Incorporated (NYSE:TDG) were released by: Streetinsider.com and their article: “TransDigm Group (TDG) Names Kevin Stein as President and CEO and W. Nicholas Howley as Executive Chairman” published on April 30, 2018 as well as Streetinsider.com‘s news article titled: “Tiger Global’s 13F Shows New Stake in Twitter (TWTR), Mercado (MELI), Increases Stake in Amazon (AMZN) (more…)” with publication date: May 15, 2018.

Among 20 analysts covering Transdigm Group Incorporated (NYSE:TDG), 11 have Buy rating, 1 Sell and 8 Hold. Therefore 55% are positive. Transdigm Group Incorporated had 83 analyst reports since August 4, 2015 according to SRatingsIntel. Canaccord Genuity maintained TransDigm Group Incorporated (NYSE:TDG) on Thursday, March 23 with “Buy” rating. The firm has “Sell” rating by J.P. Morgan given on Tuesday, December 12. The firm earned “Hold” rating on Monday, January 8 by Jefferies. The stock has “Buy” rating by Deutsche Bank on Wednesday, August 9. The stock of TransDigm Group Incorporated (NYSE:TDG) has “Buy” rating given on Tuesday, February 6 by RBC Capital Markets. As per Thursday, February 8, the company rating was upgraded by Stephens. The stock of TransDigm Group Incorporated (NYSE:TDG) has “Buy” rating given on Friday, May 26 by Canaccord Genuity. RBC Capital Markets maintained TransDigm Group Incorporated (NYSE:TDG) on Friday, October 6 with “Buy” rating. Canaccord Genuity maintained the stock with “Buy” rating in Wednesday, August 9 report. As per Wednesday, August 10, the company rating was maintained by Barclays Capital.

Investors sentiment increased to 1 in 2017 Q4. Its up 0.07, from 0.93 in 2017Q3. It is positive, as 27 investors sold TDG shares while 130 reduced holdings. 43 funds opened positions while 114 raised stakes. 55.96 million shares or 1.17% less from 56.62 million shares in 2017Q3 were reported. Financial Architects has 50 shares for 0% of their portfolio. Cubist Systematic Strategies Ltd accumulated 1,950 shares. Japan-based Nomura Asset Communication Ltd has invested 0.02% in TransDigm Group Incorporated (NYSE:TDG). Virtus Invest Advisers holds 0.05% or 3,702 shares. Korea Investment Corporation accumulated 495 shares. King Luther Cap Mgmt Corporation holds 0.01% of its portfolio in TransDigm Group Incorporated (NYSE:TDG) for 3,270 shares. 2,135 are owned by Ls Advsr Ltd. Calamos Advsr Limited Co has invested 0.02% of its portfolio in TransDigm Group Incorporated (NYSE:TDG). 1.80 million are owned by Stockbridge Partners Ltd Com. Ancora Advisors Ltd Liability Corp reported 0.06% stake. Arizona State Retirement System invested 0.06% in TransDigm Group Incorporated (NYSE:TDG). Meag Munich Ergo Kapitalanlagegesellschaft Mbh, Germany-based fund reported 2,312 shares. 5.45 million are owned by Ww. American Century Cos Incorporated stated it has 0% of its portfolio in TransDigm Group Incorporated (NYSE:TDG). Ameritas Inv Prtn holds 1,046 shares or 0.01% of its portfolio.

Since January 16, 2018, it had 1 insider purchase, and 16 selling transactions for $45.36 million activity. Another trade for 11,900 shares valued at $3.48 million was made by Laubenthal Raymond F on Thursday, March 15. Stein Kevin M bought 1,347 shares worth $399,774. Valladares Jorge also sold $997,184 worth of TransDigm Group Incorporated (NYSE:TDG) on Tuesday, April 10. $4.75 million worth of TransDigm Group Incorporated (NYSE:TDG) shares were sold by Peacock Douglas W. Jones Roger also sold $1.47 million worth of TransDigm Group Incorporated (NYSE:TDG) shares. $5.00M worth of stock was sold by Henderson Robert S on Friday, May 11. $1.73 million worth of TransDigm Group Incorporated (NYSE:TDG) shares were sold by Reiss Joel.

TransDigm Group Incorporated (NYSE:TDG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ellis Scott

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: